At a glance
- Originator Nonindustrial source
- Class Antibacterials; Antifungals; Macrolides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Aspergillosis; Immunological disorders
Most Recent Events
- 13 Nov 2001 No-Development-Reported for Aspergillosis in Japan (Unknown route)
- 13 Nov 2001 No-Development-Reported for Immunological disorders in Japan (Unknown route)
- 08 Jun 1998 New profile